In the BioHarmony Drug Report Database
Ciclesonide
Alvesco, Omnaris, Zetonna (ciclesonide) is a small molecule pharmaceutical. Ciclesonide was first approved as Alvesco on 2006-10-20. It is used to treat allergic rhinitis perennial and allergic rhinitis seasonal in the USA. The pharmaceutical is active against glucocorticoid receptor. Alvesco’s patent is valid until 2028-02-01 (FDA).
Trade Name
|
Alvesco, Omnaris, Zetonna |
|---|---|
Common Name
|
ciclesonide |
ChEMBL ID
|
CHEMBL2040682 |
Indication
|
allergic rhinitis perennial, allergic rhinitis seasonal |
Drug Class
|
Topical steroids (acetal derivatives) |
Image (chem structure or protein)